About MBF Therapeutics
MBF Therapeutics is a private company based in Ambler, Pennsylvania. It has reported $2,964,477 raised in five offerings on Form D since March 2009.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 29, 2023 | Jan 8, 2024 | $105,000of $500K target | 6 | $17,500 | Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Aug 20, 2020 | Sep 1, 2020amended Sep 21, 2021 | $814,292of $3.0M target | 21 | $38,776 | Equity, Options, Securities on exerciseRule 506(b) | Form D/A ↗1 earlier filing |
| Oct 11, 2017 | Nov 16, 2017amended May 24, 2019 | $605,000of $2.0M target | 16 | $37,813 | Debt, Options, Securities on exerciseRule 506(b) | Form D/A ↗2 earlier filings |
| Nov 10, 2016 | Nov 21, 2016 | $1,095,185fully sold | 14 | $78,228 | Equity, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Mar 5, 2009 | Mar 17, 2009amended Mar 15, 2010 | $345,000of $1.0M target | 7 | $49,286 | Debt, Options, Securities on exercise06 | Form D/A ↗1 earlier filing |
| Total, five offerings | $2,964,477 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on MBF Therapeutics's Form D filed Jan 8, 2024.
DT
Dhiren Thakker
Director
JC
Joseph Connor
Director
AP
Aris Persidis
Director
LK
Lorraine Keller
Executive officer
TT
Thomas Tillett
President and director
CC
Christopher Cashman
Director
Earlier filings also listed Chris Bunge (director, last listed Sep 2021) and Christopher Ragland (director, last listed Mar 2010).